BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33965291)

  • 1. Systemic therapies in elderly patients with advanced hepatocellular carcinoma: do not forget metronomic capecitabine.
    Kapacee ZA; McNamara MG; de Liguori Carino N; Lamarca A; Valle JW; Hubner RA
    Eur J Surg Oncol; 2021 Aug; 47(8):2209-2210. PubMed ID: 33965291
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic therapies in elderly patients with advanced hepatocellular carcinoma: Do not forget metronomic capecitabine.
    Wilhelmi M
    Eur J Surg Oncol; 2021 Aug; 47(8):2208. PubMed ID: 33906788
    [No Abstract]   [Full Text] [Related]  

  • 3. Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases.
    Brandi G; Venturi M; De Lorenzo S; Garuti F; Frega G; Palloni A; Garajovà I; Abbati F; Saccoccio G; Golfieri R; Pantaleo MA; Barbera MA
    Cancer Commun (Lond); 2018 Jun; 38(1):41. PubMed ID: 29941039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The power of kindness: curative treatment with metronomic combination in advanced hepatocellular carcinoma.
    Brandi G; Di Federico A; Rizzo A; De Lorenzo S; Vasuri F; Brocchi S; Golfieri R; Morelli MC; Frega G; Palloni A
    Anticancer Drugs; 2022 Jan; 33(1):e781-e783. PubMed ID: 34407053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lasting response with metronomic capecitabine in advanced hepatocellular carcinoma.
    Ballardini P; Marri I; Margutti G; Aliberti C; Benea G; Manfredini R
    Tumori; 2010; 96(5):768-70. PubMed ID: 21302626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durable complete response of hepatocellular carcinoma after metronomic capecitabine.
    Brandi G; de Rosa F; Bolondi L; Agostini V; Di Girolamo S; Nobili E; Biasco G
    Tumori; 2010; 96(6):1028-30. PubMed ID: 21388070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation.
    Ravaioli M; Cucchetti A; Pinna AD; De Pace V; Neri F; Barbera MA; Maroni L; Frega G; Palloni A; De Lorenzo S; Ripoli MC; Pantaleo MA; Cescon M; Del Gaudio M; Brandi G
    Sci Rep; 2017 Sep; 7(1):11305. PubMed ID: 28900245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metronomic capecitabine in advanced hepatocellular carcinoma patients: a phase II study.
    Brandi G; de Rosa F; Agostini V; di Girolamo S; Andreone P; Bolondi L; Serra C; Sama C; Golfieri R; Gramenzi A; Cucchetti A; Pinna AD; Trevisani F; Biasco G;
    Oncologist; 2013; 18(12):1256-7. PubMed ID: 24232581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure.
    Granito A; Marinelli S; Terzi E; Piscaglia F; Renzulli M; Venerandi L; Benevento F; Bolondi L
    Dig Liver Dis; 2015 Jun; 47(6):518-22. PubMed ID: 25861840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metronomic capecitabine versus best supportive care as second-line treatment in hepatocellular carcinoma: a retrospective study.
    Casadei Gardini A; Foca F; Scartozzi M; Silvestris N; Tamburini E; Faloppi L; Brunetti O; Rudnas B; Pisconti S; Valgiusti M; Marisi G; Foschi FG; Ercolani G; Tassinari D; Cascinu S; Frassineti GL
    Sci Rep; 2017 Feb; 7():42499. PubMed ID: 28211921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine in advanced hepatocellular carcinoma: A multicenter experience.
    Pelizzaro F; Sammarco A; Dadduzio V; Pastorelli D; Giovanis P; Soldà C; Rizzato MD; Lombardi G; Lonardi S; Peserico G; Imondi A; Sartori A; Maddalo G; Farinati F
    Dig Liver Dis; 2019 Dec; 51(12):1713-1719. PubMed ID: 31320302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capecitabine in advanced hepatocellular carcinoma.
    Murer F; Pozzan C; Peserico G; Farinati F
    Dig Liver Dis; 2016 Oct; 48(10):1260-1. PubMed ID: 27476466
    [No Abstract]   [Full Text] [Related]  

  • 13. Capecitabine for treatment of advanced hepatocellular carcinoma.
    von Delius S; Lersch C; Mayr M; Stock K; Schulte-Frohlinde E; Schmid RM; Eckel F
    Hepatogastroenterology; 2007 Dec; 54(80):2310-4. PubMed ID: 18265654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of metronomic chemotherapy after cool-tip radiofrequency ablation in the treatment of hepatocellular carcinoma.
    Wang-Yuan Z; Jiang-Zheng Z; Lu YD; Hao XB; Hong T; Huang F; Lei JH; He ZH; Huang MZ
    Int J Hyperthermia; 2016; 32(2):193-8. PubMed ID: 26586093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic Hepatoid Carcinoma of the Pancreas: First Description of Treatment With Capecitabine and Temozolomide.
    Pellini Ferreira B; Vasquez J; Carilli A
    Am J Med Sci; 2017 Jun; 353(6):610-612. PubMed ID: 28641727
    [No Abstract]   [Full Text] [Related]  

  • 16. Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma.
    McIntosh A; Hagspiel KD; Al-Osaimi AM; Northup P; Caldwell S; Berg C; Angle JF; Argo C; Weiss G; Rich TA
    Cancer; 2009 Nov; 115(21):5117-25. PubMed ID: 19642177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial.
    Xia Y; Qiu Y; Li J; Shi L; Wang K; Xi T; Shen F; Yan Z; Wu M
    Ann Surg Oncol; 2010 Dec; 17(12):3137-44. PubMed ID: 20602260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II Trial of Sorafenib in Combination with Capecitabine in Patients with Hepatocellular Carcinoma: INST 08-20.
    Patt Y; Rojas-Hernandez C; Fekrazad HM; Bansal P; Lee FC
    Oncologist; 2017 Oct; 22(10):1158-e116. PubMed ID: 28687627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial.
    Walter I; Schulz U; Vogelhuber M; Wiedmann K; Endlicher E; Klebl F; Andreesen R; Herr W; Ghibelli L; Hackl C; Wiest R; Reichle A
    Med Oncol; 2017 Nov; 34(12):192. PubMed ID: 29098441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases.
    Shao YY; Ho MC; Cheng AL; Hsu CH
    J Formos Med Assoc; 2014 Aug; 113(8):577-8. PubMed ID: 25037767
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.